{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:21:36Z","timestamp":1789586496999,"version":"build-2803163510"},"reference-count":56,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"abstract":"<jats:p>ABSTRACT Most people infected by Mycobacterium tuberculosis (Mtb) do not have any signs or disease symptoms, a condition known as latent tuberculosis infection (LTBI). The introduction of biological agents, mainly tumor necrosis factor (TNF) inhibitors, for the treatment of immune-mediated diseases such as Rheumatoid Arthritis (RA) and other rheumatic diseases, increased the risk of reactivation of LTBI, leading to development of active TB. Thus, this review will approach the aspects related to LTBI in patients with rheumatologic diseases, especially those using iTNF drugs. For this purpose it will be considered the definition and prevalence of LTBI, mechanisms associated with diseases and medications in use, criteria for screening, diagnosis and treatment. Considering that reactivation of LTBI accounts for a large proportion of the incidence of active TB, adequate diagnosis and treatment are crucial, especially in high-risk groups such as patients with rheumatologic diseases.<\/jats:p>","DOI":"10.1590\/1806-3713\/e20190023","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:37:58Z","timestamp":1556890678000},"source":"Crossref","is-referenced-by-count":46,"title":["Latent tuberculosis infection in patients with rheumatic diseases"],"prefix":"10.1590","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-6351","authenticated-orcid":false,"given":"Camila","family":"Anton","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-7974","authenticated-orcid":false,"given":"Felipe Dominguez","family":"Machado","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-9376","authenticated-orcid":false,"given":"Jorge Mario Ahumada","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-0113","authenticated-orcid":false,"given":"Rafaela Manzoni","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-4325","authenticated-orcid":false,"given":"Pen\u00e9lope Esther","family":"Palominos","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-7912","authenticated-orcid":false,"given":"Claiton Viegas","family":"Brenol","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-6738","authenticated-orcid":false,"given":"Fernanda Carvalho de Queiroz","family":"Mello","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-2734","authenticated-orcid":false,"given":"Denise Rossato","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s10067-017-3714-6","article-title":"Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents","volume":"36","author":"Garziera G","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack U","year":"2009","journal-title":"Eur Respir J"},{"key":"ref3","series-title":"Global tuberculosis report 2018","year":"2018"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2169\/internalmedicine.53.1936","article-title":"Characteristics of tuberculosis in patients with rheumatoid arthritis a retrospective single-center study","volume":"53","author":"Ishiguro T","year":"2014","journal-title":"Intern Med"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","article-title":"Incidence of tuberculosis in patients with rheumatoid arthritis A systematic literature review","volume":"78","author":"Baronnet L","year":"2011","journal-title":"Joint Bone Spine"},{"key":"ref6","first-page":"193","article-title":"Anti-TNF therapy in Jordan a focus on severe infections and tuberculosis","volume":"8","author":"Alawneh KM","year":"2014","journal-title":"Biologics"},{"key":"ref7","series-title":"Latent tuberculosis infection - Updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"ref8","series-title":"Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","year":"2018"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2013-204960","article-title":"Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments","volume":"74","author":"Arkema EV","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling J","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ref11","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona L","year":"2003","journal-title":"J Rheumatol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/1756-185X.12375","article-title":"Tuberculosis risk and anti-tumour necrosis factor agents in rheumatoid arthritis a critical appraisal of national registry data","volume":"17","author":"Scrivo R","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"ref13","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA) effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"Seong S-S","year":"2007","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"ref14","first-page":"477","article-title":"Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases","volume":"57","author":"Yonekura CL","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","article-title":"Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis possible role for limiting pathology","volume":"69","author":"Mohan VP","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies a TBNET consensus statement","volume":"36","author":"Solovic I","year":"2010","journal-title":"Eur Respir J"},{"issue":"0","key":"ref17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3899\/jrheum.140103","article-title":"Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-a (TNF-a) targeted biologics and recently licensed TNF-a inhibitors data from clinical trials and national registries","volume":"91","author":"Cantini F","year":"2014","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"ref18","first-page":"1018","article-title":"III Brazilian thoracic association guidelines on tuberculosis","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"issue":"12","key":"ref19","first-page":"1401","article-title":"Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children","volume":"12","author":"Chan PC","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"44","key":"ref20","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/j.vaccine.2008.08.006","article-title":"The effect of Bacille Calmette-Gu\u00e9rin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis","volume":"26","author":"Araujo Z","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0889-857X(05)70204-0","article-title":"Pathogenesis of rheumatoid arthritis the role of t cells and other beasts","volume":"27","author":"Panayi GS","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tube.2006.07.006","article-title":"The level of PPD-specific IFN- -producing CD4+ T cells in the blood predicts the in vivo response to PPD","volume":"87","author":"Martins MVBS","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFa Therapy","volume":"200","author":"Ehrenstein MR","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.semarthrit.2012.07.001","article-title":"Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in korean patients with rheumatic diseases","volume":"42","author":"Kim J-H","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2012.10.017","article-title":"Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment","volume":"66","author":"Bartalesi F","year":"2013","journal-title":"J Infect"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ard.43.3.430","article-title":"Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis the role of protein energy malnutrition","volume":"43","author":"Emery P","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref27","first-page":"54","article-title":"A low prevalance of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis Association with clinical features and HRCT findings","volume":"25","author":"K\u00f6ker IH","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"ref28","first-page":"121","article-title":"Resposta atenuada ao PPD no diagn\u00f3stico de infec\u00e7\u00e3o tuberculosa latente em pacientes com artrite reumatoide","volume":"49","author":"Marques CDL","year":"2009","journal-title":"Rev Bras Reumatol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1378\/chest.06-2471","article-title":"Diagnosing tuberculosis infection in the 21st century new tools to tackle an old enemy","volume":"131","author":"Lalvani A","year":"2007","journal-title":"Chest"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.micres.2006.11.016","article-title":"A protein linkage map of the ESAT-6 secretion system 1 (ESX-1) of Mycobacterium tuberculosis","volume":"164","author":"Teutschbein J","year":"2009","journal-title":"Microbiol Res"},{"issue":"19-20","key":"ref31","first-page":"286","article-title":"Assessment of an Interferon- release assay for the diagnosis of latent tuberculosis infection in haemodialysis patients","volume":"140","author":"Hoffmann M","year":"2010","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai M","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10067-014-2817-6","article-title":"Screening of latent tuberculosis infection by interferon- release assays in rheumatic patients: a systemic review and meta-analysis","volume":"35","author":"Ruan Q","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/1756-185X.13129","article-title":"Tuberculosis and biologics in rheumatology A special situation","volume":"20","author":"Handa R","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review T-Cell - based assays for the diagnosis of latent tuberculosis infection","volume":"149","author":"Pai M","year":"2008","journal-title":"Ann Intern Med"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumatoid arthritis study in a population with a high prevalence of tuberculosis","volume":"64","author":"Le\u00f3n DP","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0482-50042011000100004","article-title":"Baixa preval\u00eancia de PPD reativo pr\u00e9via ao uso de infliximabe estudo comparativo em popula\u00e7\u00e3o amostral do Hospital Geral de Fortaleza","volume":"51","author":"Callado MRM","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5588\/ijtld.13.0755","article-title":"LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area","volume":"18","author":"Bonfiglioli KR","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"430134","DOI":"10.1155\/2014\/430134","article-title":"Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis Implications on anti-TNF therapies","volume":"2014","author":"Agarwal S","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5588\/ijtld.12.0111","article-title":"Screening for latent tuberculosis in anti-TNF-a candidate patients in a high tuberculosis incidence setting","volume":"16","author":"Saidenberg-Kermanac'h N","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref41","series-title":"LTBI: a guide for primary health care providers - Diagnosis of latent TB infection","year":"2019"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh JA","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh JA","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2014-205376","article-title":"Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases","volume":"74","author":"Hatzara C","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"TNMI7","DOI":"10.1128\/microbiolspec.TNMI7-0039-2016","article-title":"Treatment of latent tuberculosis infection","volume":"5","author":"Haley CA","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40506-017-0135-7","article-title":"Treatment of latent tuberculosis infection","volume":"9","author":"Tang P","year":"2017","journal-title":"Curr Treat Options Infect Dis"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong","volume":"145","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies D","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/427802","article-title":"Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection a meta-analysis","volume":"40","author":"Ena J","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and rifampin","volume":"99","author":"Steele MA","year":"1991","journal-title":"Chest"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson NA","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine isoniazid or daily rifampin pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter M","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"ref53","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling TR","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-rifapentine for latent tuberculosis infection a systematic review and meta-analysis","volume":"55","author":"Njie GJ","year":"2018","journal-title":"Am J Prev Med"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"1801470","DOI":"10.1183\/13993003.01470-2018","article-title":"Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients a randomised controlled study","volume":"52","author":"Gao L","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"1802180","DOI":"10.1183\/13993003.02180-2018","article-title":"New short regimens for latent tuberculosis treatment safety first!","volume":"52","author":"Menzies D","year":"2018","journal-title":"Eur Respir J"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v45n2\/1806-3713-jbpneu-45-02-e20190023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T17:25:55Z","timestamp":1581096355000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132019000200502&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019]]}},"alternative-id":["S1806-37132019000200502"],"URL":"https:\/\/doi.org\/10.1590\/1806-3713\/e20190023","relation":{},"ISSN":["1806-3756","1806-3713"],"issn-type":[{"value":"1806-3756","type":"electronic"},{"value":"1806-3713","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e20190023"}}